PLAGL2 and glioblastoma: For example, a study demonstrated a contribution of pleomorphic adenoma gene-like 2 (PLAGL2) into GBM stemness triggering of the canonical pathway, such as Wnt6, FZD9, and FZD2, confirming a PLAGL2 overexpression in GBM [92].